Close



Nov 24, 2021 09:12AM
Nov 24, 2021 09:12AM
Oct 11, 2021 09:21AM
Oct 11, 2021 06:30AM
Oct 11, 2021 06:30AM
Oct 11, 2021 06:30AM
Oct 1, 2021 09:15AM Adamas Named 2021 Finalist in the New Therapeutics Category of the UCSF Health Awards
Sep 30, 2021 09:09AM
Sep 16, 2021 09:15AM
Aug 9, 2021 04:01PM
Jul 22, 2021 09:15AM
Jul 22, 2021 09:15AM
Jun 10, 2021 09:16AM
Jun 10, 2021 09:15AM New Data Analysis Supports GOCOVRI as an Important Treatment for Motor Complications for People With Parkinson’s Disease
May 10, 2021 04:02PM
Apr 15, 2021 09:15AM
Mar 29, 2021 09:15AM
Mar 29, 2021 09:15AM
Feb 23, 2021 04:03PM
Feb 5, 2021 11:37AM
Feb 1, 2021 02:07PM Adamas Pharma (ADMS) Announces FDA Approval for Second Indication for GOCOVRI as Adjunctive Treatment to levodopa/carbidopa in Parkinson’s Disease Patients Experiencing OFF Episodes
Feb 1, 2021 02:07PM
Feb 1, 2021 08:01AM
Jan 13, 2021 09:17AM
Jan 13, 2021 09:15AM
Jan 5, 2021 09:15AM
Dec 2, 2020 06:53AM
Dec 2, 2020 06:51AM Adamas Announces Agreement to Amend Royalty-Backed Loan Agreement with HealthCare Royalty Partners
Dec 2, 2020 06:50AM
Dec 2, 2020 06:50AM
Nov 5, 2020 04:03PM
Sep 11, 2020 04:04PM
Sep 11, 2020 09:17AM
Sep 11, 2020 09:15AM
Sep 8, 2020 04:05PM Adamas to Present at Upcoming HC Wainwright Conference
Aug 14, 2020 04:04PM
Aug 6, 2020 04:02PM
Jul 23, 2020 04:02PM
Jul 15, 2020 08:03AM
Jul 15, 2020 08:00AM
Jul 10, 2020 04:05PM
Jun 18, 2020 09:26AM Pre-Open Stock Movers 06/18: (ALPN) (AEMD) (ELOX) Higher; (LPTX) (QUIK) (BIIB) Lower (more...)
Jun 17, 2020 04:02PM
Jun 17, 2020 04:01PM
Jun 5, 2020 09:23AM
Jun 5, 2020 07:46AM
Jun 4, 2020 05:26PM
Jun 4, 2020 04:31PM
Jun 4, 2020 04:30PM Adamas announces FDA filing acceptance of sNDA to modify the indication statement for GOCOVRI® to include treatment for Parkinson’s disease patients receiving levodopa and experiencing OFF episodes
Jun 3, 2020 04:01PM

251,398 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All